Inagene Diagnostics Inc. offers personalized medicine
TORONTO, Nov. 18, 2021 (GLOBE NEWSWIRE) – Since cannabis was legalized in 2018, interest in its medical application has skyrocketed. Canadian consumers and health care providers are seeking advice to ensure that cannabis products are not only safe, but that they provide the desired clinical effect. Recognizing the important role that genetics play in the way people respond to cannabis products, Inagene diagnosis is committed to supporting the advancement of science and has launched a genetic test that supports personalization of cannabis treatment. The comprehensive test, which predicts an individual’s response to cannabis products based on their unique genetic profile, is included in their pharmacogenetic test for pain and mental health.
Although cannabis is widely used to treat multiple medical conditions, much is still unknown about how to optimize its use, and there is wide variation in responses to cannabis products between individuals. As the evidence accumulates, there remains a compelling need for advice on how best to harness cannabis for successful treatment. Inagene’s test provides Canadians with access to information that will help them and their health care providers determine whether cannabis may be a good option and, if so, what strain, dose and route to take. administration can produce the best therapeutic response. “Inagene offers a simple DNA swab test that provides a wealth of information for those looking to make better decisions about their health. Compared to other pharmacogenetic tests, Inagene’s results are easy to understand and actionable, ”said David Berg, President and CTO of Strainprint.
The cheek swab test kit is ordered online and mailed to Inagene’s lab in Toronto, with results delivered in just 7 days through the company’s secure online portal. The easy-to-understand report details expected responses to more than 140 drugs, including recommendations for preliminary data on prescription cannabis, CBD, THC, and synthetic cannabinoids.
Many cannabis users also use conventional drugs, and cannabis products can interact with other drugs, making them less effective or producing unexpected side effects, all of which can be determined by an individual’s genetic profile. In addition to information to guide cannabis product and dose selection, the report includes preliminary data that can help predict the likelihood of psychosis, cognitive problems, risk of developing problematic cannabis use, and others. long-term complications to which some people are genetically more prone. To.
“People are overwhelmed when they see the cannabis product options available,” says Nancy White, CEO of Inagene, “… and medical professionals can only give advice, like start low. dose and slow down, or avoid high doses of THC if they have it. anxiety. Many may have tried cannabis in the past and gave it up if they didn’t get the effect they expected, when they just needed a different dose or a different ratio of CBD versus THC. “The addition of Inagene’s PGx cannabis test supports our ability to provide evidence-based cannabis recommendations, enabling a truly personalized and holistic wellness plan,” says Anushya Vijayaraghevan, pharmacist and co-founder , Apothecare Chemists Inc. Without this kind of personalized information, people can rely on the opinions of friends, or Google searches to provide them with the information they are looking for and this is not always reliable.
About Inagene Diagnostics Inc.
Inagene ™ Diagnostics Inc. is a Canadian CLIA accredited pharmacogenetic testing company located in Toronto. Inagene Personalized Insights ™ testing is focused on providing comprehensive and reliable genetic testing to guide drug selection and treatment. Learn more about www.inagene.com
Founded in Toronto in 2016, Strainprint Technologies Ltd. is the leading cannabis data and analytics company Real World Evidence. With the world’s largest longitudinal observational dataset and a mission to advance scientific understanding of cannabis and its legitimacy as a traditional therapy, Strainprint helps medical cannabis patients and physicians use cannabis from in the most efficient and responsible way possible.
About Apothecare Chemists
Apothecare Chemists are a team of expert pharmacists who provide personalized cannabis consultation solutions to healthcare professionals and patients, working in conjunction with community pharmacists and cannabis retail stores to provide recommendations for evidence-based cannabis.
Note to editors:
For more information, please contact:
Neelam Bance Parsons, Inagene Diagnostics